Ilypsa

About:

Ilypsa is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.

Top Investors: U.S. Venture Partners, 5AM Ventures, Delphi Ventures, Johnson & Johnson Development Corporation, Sprout Group

Description:

It discovers and develops renal care pharmaceutical products. It develops non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. The company, formerly known as Symyx Therapeutics, Inc. was founded in 2002 and is based in Santa Clara, California.

Total Funding Amount:

$44M

Headquarters Location:

Santa Clara, California, United States

Founded Date:

2002-01-01

Contact Email:

investor.relations(AT)amgen.com

Founders:

Dominique Charmot

Number of Employees:

10001+

Last Funding Date:

2005-07-19

IPO Status:

Private

Industries: